Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

URGNURGN
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in UROGEN PHARMA LTD

BANK OF AMERICA CORP /DE/ holds 475,702 shares of URGN (UROGEN PHARMA LTD), worth $17.5M as of 2026-Q2. The position was increased (+275.2% shares). URGN represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$17.5M

Current Shares

475,702

Total Value Change

+$16.7M

Total Shares Change

+403,230

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
475,702
+275.2%
$17.5M0.0%$36.80
46
2026-Q1
Decreased
126,783
-1.4%
$2.3M0.0%$18.82
0
2025-Q4
Increased
128,630
+18.6%
$3M0.0%$23.17
31
2025-Q3
Decreased
108,454
-59.1%
$2.2M0.0%$19.14
0
2025-Q2
Increased
265,117
+34.7%
$3.6M0.0%$13.49
34
2025-Q1
Increased
196,802
+171.6%
$2.2M0.0%$11.20
42
2024-Q4
New
72,472
-
$771,8260.0%$10.52
34

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used